PerkinElmer is hoping that a variety of life science research instruments it launched in 2005 will drive revenue in 2006 and help the firm meet its forecast of 5-percent to 7-percent organic growth this year.

Company officials said during a conference call last week that they expect the shift in the firm's product mix in 2005 to match the market's "migration of applications." Specifically, they believe PerkinElmer's growing focus on cell analysis and protein biomarkers should fuel revenue growth.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.